Holger Hans Hermann Erb (Holger H H Erb)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Venues

Cancers

International journal of molecular sciences

Oncogene

Journal of translational medicine

Urologisches Labor

Innsbruck Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Urologisches Labor

Germany

Deputy Laboratory Manager :: Klinik und Poliklinik für Urologie und Kinderurologie

YCR Cancer Research Unit

United Kingdom

Postdoctoral position :: Biology

Department of Experimental Urology

Austria

Postdoctoral position :: Innsbruck Medical University

Department of Experimental Urology

Austria

PhD fellow in the FP7 Marie Curie Initial Training Network “PRO-NEST” :: Department of Experimental Urology

Education History

Innsbruck Medical University May 01 2009 - Oct 31 2013

Austria

PHD :: Department of Experimental Urology

Publications

Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, Eva Szczyrbová, Susanne Fuessel, Martin Puhr, Johannes Linxweiler, Shivani Yalala, Wilbert T Zwart, Aria Baniahmad, Jasper van Goubergen, Harri M Itkonen, Adam Sharp, Edward O'Neill, Marc Pretze, Matthias Miederer, Holger Hans Hermann Erb
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F van de Merbel, Anna Dubrovska, Guido Jenster, Christof Bernemann, Ulrich Sommer, Holger Hans Hermann Erb
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of translational medicine 22 (1) (2024)
Holger Hans Hermann Erb, Nikita Polishchuk, Oleh Stasyk, Uğur Kahya, Matthias M Weigel, Anna Dubrovska
Glutamine Metabolism and Prostate Cancer. Cancers 16 (16) (2024)
Holger Hans Hermann Erb, Nikita Polishchuk, Oleh Stasyk, Uğur Kahya, Matthias M Weigel, Anna Dubrovska
Glutamine Metabolism and Prostate Cancer. Cancers 16 (16) (2024)
Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, Eva Szczyrbová, Susanne Fuessel, Martin Puhr, Johannes Linxweiler, Shivani Yalala, Wilbert T Zwart, Aria Baniahmad, Jasper van Goubergen, Harri M Itkonen, Adam Sharp, Edward O'Neill, Marc Pretze, Matthias Miederer, Holger Hans Hermann Erb
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F van de Merbel, Anna Dubrovska, Guido Jenster, Christof Bernemann, Ulrich Sommer, Holger Hans Hermann Erb
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of translational medicine 22 (1) (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Pia V Hönscheid, Gustavo B Baretton, Martin Puhr, Tiziana Siciliano, Justus S Israel, Matthias B Stope, Celina Ebersbach, Alicia-Marie K Beier, Christian Thomas, Holger Hans Hermann Erb
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation. International journal of molecular sciences 25 (17) (2024)
Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F van de Merbel, Anna Dubrovska, Guido Jenster, Christof Bernemann, Ulrich Sommer, Holger Hans Hermann Erb
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of translational medicine 22 (1) (2024)
Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, Eva Szczyrbová, Susanne Fuessel, Martin Puhr, Johannes Linxweiler, Shivani Yalala, Wilbert T Zwart, Aria Baniahmad, Jasper van Goubergen, Harri M Itkonen, Adam Sharp, Edward O'Neill, Marc Pretze, Matthias Miederer, Holger Hans Hermann Erb
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F van de Merbel, Anna Dubrovska, Guido Jenster, Christof Bernemann, Ulrich Sommer, Holger Hans Hermann Erb
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of translational medicine 22 (1) (2024)
Andreas Nitsch, Caroline Sander, Benedikt Eggers, Martin Weiss, Eva Katharina Egger, Franz-Josef Kramer, Holger Hans Hermann Erb, Alexander Mustea, Matthias B Stope
Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy. Cancers 15 (2) (2023)
Andreas Nitsch, Caroline Sander, Benedikt Eggers, Martin Weiss, Eva Katharina Egger, Franz-Josef Kramer, Holger Hans Hermann Erb, Alexander Mustea, Matthias B Stope
Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy. Cancers 15 (2) (2023)
Alicia-Marie K Beier, Martin Puhr, Matthias B Stope, Christian Thomas, Holger Hans Hermann Erb
Metabolic changes during prostate cancer development and progression. Journal of cancer research and clinical oncology (2022)
Celina Ebersbach, Alicia-Marie K Beier, Pia Hönscheid, Christian Sperling, Korinna Jöhrens, Gustavo B Baretton, Christian Thomas, Ulrich Sommer, Angelika Borkowetz, Holger Hans Hermann Erb
Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue. Life (Basel, Switzerland) 12 (2) (2022)
Tiziana Siciliano, Ulrich Sommer, Alicia-Marie K Beier, Matthias B Stope, Angelika Borkowetz, Christian Thomas, Holger Hans Hermann Erb
The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity. Current issues in molecular biology 44 (2) (2022)
Dinah Linke, Lukas Donix, Claudia Peitzsch, Holger Hans Hermann Erb, Anna Dubrovska, Manuel Pfeifer, Christian Thomas, Susanne Fuessel, Kati Erdmann
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International journal of molecular sciences 24 (1) (2022)
Dinah Linke, Lukas Donix, Claudia Peitzsch, Holger Hans Hermann Erb, Anna Dubrovska, Manuel Pfeifer, Christian Thomas, Susanne Fuessel, Kati Erdmann
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International journal of molecular sciences 24 (1) (2022)
Dinah Linke, Lukas Donix, Claudia Peitzsch, Holger Hans Hermann Erb, Anna Dubrovska, Manuel Pfeifer, Christian Thomas, Susanne Fuessel, Kati Erdmann
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International journal of molecular sciences 24 (1) (2022)
Ulrich Sommer, Tiziana Siciliano, Celina Ebersbach, Alicia-Marie K Beier, Matthias B Stope, Korinna Jöhrens, Gustavo B Baretton, Angelika Borkowetz, Christian Thomas, Holger Hans Hermann Erb
Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells. International journal of molecular sciences 23 (3) (2022)
Tiziana Siciliano, Ingo H Simons, Alicia-Marie K Beier, Celina Ebersbach, Cem Aksoy, Robert I Seed, Matthias B Stope, Christian Thomas, Holger Hans Hermann Erb
A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response. Life (Basel, Switzerland) 11 (9) (2021)
Celina Ebersbach, Alicia-Marie K Beier, Christian Thomas, Holger Hans Hermann Erb
Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer. Cancers 13 (19) (2021)
Christian Thomas, Martin Baunacke, Holger Hans Hermann Erb, Susanne Füssel, Kati Erdmann, Juliane Putz, Angelika Borkowetz
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored? Cancers 14 (1) (2021)
Holger Hans Hermann Erb, Julia Bodenbender, Florian Handle, Tamara Diehl, Lukas Donix, Igor Tsaur, Martin Gleave, Axel Haferkamp, Johannes Huber, Susanne Fuessel, Eva Juengel, Zoran Culig, Christian Thomas
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. PloS one 15 (8) (2020)
Holger Hans Hermann Erb, Marlies Ebert, Ronja Kuhn, Lukas Donix, Axel Haferkamp, Robert Ian Seed, Eva Jüngel
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target. PloS one 14 (10) (2019)
Robert I Seed, Alberto J Taurozzi, Daniel J Wilcock, Giovanna Nappo, Holger Hans Hermann Erb, Martin L Read, Xianfeng Ding, Leanne K Archer, Saburo Ito, Martin G Rumsby, John L Petrie, Aled Clayton, Norman J Maitland, Anne T Collins
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy. Scientific reports 9 (1) (2019)

Holger Hans Hermann Erb.css-eqlu8i{font-size:small;padding-left:4px;} (Holger H H Erb)

Publication Activity (10 Years)

Top Topics

Top Venues

Holger Hans Hermann Erb (Holger H H Erb)